Company Captor Capital Corp Canadian Securities Exchange
Equities
CA14075H1038
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabis
100.0
%
| 33 | 100.0 % | 42 | 100.0 % | +27.80% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 33 | 100.0 % | 42 | 100.0 % | +27.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Zorbas
CEO | Chief Executive Officer | 53 | 31/12/17 |
Jing Peng
DFI | Director of Finance/CFO | 47 | 28/02/14 |
Gavin Davidson
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Klein
BRD | Director/Board Member | 50 | 20/11/19 |
Kyle Appleby
BRD | Director/Board Member | 48 | 30/06/14 |
John Zorbas
CEO | Chief Executive Officer | 53 | 31/12/17 |
Brady Cobb
CHM | Chairman | - | 17/05/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,934,299 | 51,034,862 ( 98.27 %) | 0 | 98.27 % |
Company contact information
![address Captor Capital Corp](https://cdn.zonebourse.com/static/address/38508999.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+29.76% | 5.69B | |
-32.34% | 3.53B | |
-2.23% | 3.06B | |
-25.26% | 2.62B | |
-10.88% | 2.29B | |
+40.09% | 1.86B | |
+40.90% | 1.43B | |
-15.16% | 1.41B | |
+42.86% | 1.4B |